Document:USA FDA INFORMATION SHEET - Recruiting Study Subjects, Guidance for Institutional Review Boards and Clinical Investigators Jan-1998
From GxPlex
| Document information | |
|---|---|
| Reference | USA FDA INFORMATION SHEET -
Recruiting Study Subjects, Guidance for Institutional Review Boards and Clinical Investigators Jan-1998 |
| Validity area | USA |
| Scope(s) | HM |
| Document name | FDA INFORMATION SHEET -
Recruiting Study Subjects, Guidance for Institutional Review Boards and Clinical Investigators |
| Version / Revision | Jan-1998 |
| Status | Current |
| Document type | Official recommendation |
| Language(s) | EN |
| Description | INFORMATION SHEET
Recruiting Study Subjects Guidance for Institutional Review Boards and Clinical Investigators |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
References
| Reference | Scope | Document part | Language | Preview |
|---|---|---|---|---|
| Reference:USA FDA INFORMATION SHEET - Recruiting Study Subjects, Guidance for Institutional Review Boards and Clinical Investigators Jan-1998 - | HM | - | EN | FDA requires that an Institutional Review Board (IRB) review and have authority to approve, requiremodifications in, or disapprove all research activities covered by the IRB regulations [21 ... |
